Edition:
United Kingdom

Applied DNA Sciences Says Entered Into Agreement With Unit Of Theracann


Wednesday, 3 Apr 2019 

April 3 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA SCIENCES SAYS ON MARCH 28, CO, UNIT ENTERED INTO PATENT & KNOW-HOW LICENSE & COOPERATION AGREEMENT WITH A UNIT OF THERACANN - SEC FILING.APPLIED DNA SCIENCES - UNDER AGREEMENT, A $5 MILLION NON-REFUNDABLE UP-FRONT LICENSING FEE IS PAYABLE TO CO AND ITS UNIT OVER A FOUR-MONTH PERIOD. 

Company Quote

0.5579
 --
22 May 2019